Dry Extract From Psilocybe Cubensis (15-25:1), Extraction Solvent: Methanol — Drug Intelligence | 15 EU Trials

Filter these 15 trials by condition, phase, country and more.

Open in Search →

15 Registered trials

8 Recruiting

0 Completed trials

14 Sponsors

7 Countries

Phase II

Phase I/II

Phase II: 12 Phase I/II: 2 Phase I (Other): 1

Indications tested

Alcohol abuse 1 Gambling disorder 1 Anorexia nervosa 1

Sponsors using this IMP

Kobenhavns Universitet 2 Koebenhavns Universitet 2 Rigshospitalet 2 Amsterdam UMC 1 ARQ National Psychotrauma Centrum 1 Association Hospitaliere De Bruxelles Et De Schaerbeek Centre Hospitalier Universitaire Brugmann 1 Centre Hospitalier Universitaire De Nantes 1 Groupe Hospitalier Universitaire Paris Psychiatrie & Neuroscience 1 Linkopings Universitet 1 Region Hovedstaden 1 Region Skane 1 Universita' Degli Studi G. D'Annunzio Di Chieti 1

All trials

15 total

Boosting recovery through excitation of arousal and awareness in comatose patients (BREA2KTHROUGH) Not authorised

2023-503617-30-01 Phase I/II 1 country Rigshospitalet
The Acute and Long-term Impact of Support and Music in Psilocybin Therapy for Depression: The Psilocybin Setting Trial (PSISET) Not authorised

2025-522961-31-00 Phase II 1 country Kobenhavns Universitet; Koebenhavns Universitet
POSITRON - PsilOcybin with pSychologIcal supporT foR cOcaiNe: a randomised controlled pilot feasibility trial of psilocybin with psychologic… Pending

2024-515147-32-02 Phase II 1 country Trinity College Dublin
The therapeutic potential of psilocybin in anorexia nervosa in young adults Pending

2024-515163-63-00 Phase II 1 country Region Skane
Psilocybin-Assisted Psychotherapy for Posttraumatic Stress Disorder in Military Veterans: A Pilot Feasibility Study Pending

2025-521488-11-00 Phase II 1 country ARQ National Psychotrauma Centrum
Psilocybin AsSisted pSychotherapy for the treatmENt of Gambling disordER : a pilot study Pending

2025-522743-18-00 Phase II 1 country Centre Hospitalier Universitaire De Nantes
The Acute and Long-term Impact of Support in Psilocybin Therapy for Depression: The Psilocybin Setting Trial (PSISET) Pending

2025-522961-31-01 Phase II 1 country Kobenhavns Universitet; Koebenhavns Universitet
Efficacy of psilocybin and trazodone combination in treatment-resistant depression: a randomized controlled proof-of-concept study (PSILOTRA… Recruiting

2024-512911-34-00 Phase II 1 country Groupe Hospitalier Universitaire Paris Psychiatrie & Neuroscience
Psilocybin versus Personalized Neuromodulation for Resistant Depression (PSILO-MODULATION) Recruiting

2024-519844-34-03 Phase II 1 country Universita' Degli Studi G. D'Annunzio Di Chieti
Soothing Pain After ChEmotherapy: Psilocybin As INtervention (SPACE-PAIN) — a randomized controlled pilot trial Recruiting

2024-516936-93-02 Phase II 1 country Amsterdam UMC
A double-blind, randomized, controlled trial on the effect of PEX010 for prolonged grief disorder Recruiting

2024-518218-24-00 Phase II 1 country Linkopings Universitet
Boosting recovery through excitation of arousal and awareness in comatose patients: Dose finding study (BREA2KTHROUGH DOSEFINDER) Recruiting

2023-503617-30-02 Phase I (Other) 1 country Rigshospitalet
Psilocybin for hospitalized patients with treatment-resistant depression Recruiting

2022-501857-35-00 Phase II 1 country Universitair Ziekenhuis Gent
Psilocybin-Assisted Therapy for Severe Alcohol Use Disorder. Recruiting

2024-518061-10-00 Phase II 1 country Association Hospitaliere De Bruxelles Et De Schaerbeek Centre Hospitalier Univer…
Can a single dose of psilocybin reduce alcohol intake in patients with alcohol use disorder? Recruiting

2024-517497-17-01 Phase I/II 1 country Region Hovedstaden

Showing 1–15 of 15 trials

← All drugs A–Z